On a Mission to End Needless Diabetes Suffering for
100 Million People.
Scott Hepford
Founder & CEO, WellCell Global
Science
Addressing diabetes at the root cause, with a patented treatment protocol validated by more than a dozen peer-reviewed research papers.
Leadership
Built and scaled a treatment protocol to 186+ locations worldwide through mission-driven leadership and strategic collaboration.
Philanthropy
Ten years of empowering communities in Uganda and training global health leader across 17 countries.
Meet Scott A. Hepford
Scott is a biotech CEO, serial entrepreneur, and published researcher based in Houston. As Founder and CEO of Well Cell Global, he has spent the past decade advancing a patented treatment protocol for diabetes and metabolic disorders now used on six continents. From clinical innovation to global health initiatives in Uganda, his mission is simple: equip people with the right tools and they rise.
Scott is a serial entrepreneur and visionary in the health care space who has championed innovative approaches to treating metabolic disorders.
University of Buffalo
From clinical innovation to global health initiatives in Uganda, his mission is simple:
Equip people with the right tools and they rise.
Equip people with the right tools and they rise.
